AMO Ireland

Advanced Medical Optics, Inc. (AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Advanced Medical Optics, Inc. (AMO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. The company focuses on developing a broad suite of innovative technologies and devices to address a wide range of eye disorders. Today AMO operates in three strategic Business Unit Groups.

Products in the Cataract Refractive Surgery and the Corneal Refractive Surgery Groups include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery.

AMO owns or has the rights to Cataract Refractive Surgery and Corneal Refractive Surgery product brands as ReZoom™, Clariflex®, Array®, Sensar®, CeeOn®, Tecnis® and Verisyse™ intraocular lenses, STAR S4 IR™ laser vision correction system, WaveScan Wavefront® System, CustomVue™ procedure, Sovereign® and Sovereign® Compact™ phacoemulsification systems with WhiteStar® technology, Amadeus™ and Amadeus™ II microkeratomes, Healon® viscoelastics, and the Baerveldt® glaucoma shunt.

Products in the Eye Care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE® MoisturePLUS™, COMPLETE® Blink-N-Clean®, Consept®F, Consept® 1 Step, Oxysept® 1 Step, UltraCare®, Ultrazyme®, Total Care™ and blink™ branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd.

AMO became an independent company in June 2002 following a spin-off from Allergan, Inc. AMO is based in Santa Ana, California, and employs approximately 3,800 people worldwide. The company has operations in 24 countries and markets products in approximately 60 countries.